2013 is a symbolic, last major transitional year for Greatbatch (GB). With realignment of its organizational structure announced this June, the company symbolically completed a transformational period of the past eight years in which this medical appliances and equipment company successfully integrated and consolidated its organization.
With that mission accomplished by the end of 2013, the company will start to reap benefits of more effective operations, higher margins and increased EPS. It can now set sights squarely on its growth target to achieve 5 percent organic growth or better and 7% to 13% EPS improvement as the company is gradually progressing from strictly a developer of components and sub-assemblies to an organization also capable of developing complete...
Only subscribers can access this article, which is part of the PRO research library covering 3,773 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: